The European Medicines Agency (EMA) has agreed to review Vifor Pharma and ChemoCentryx’s application requesting the approval…
Articles by Marta Figueiredo, PhD
High blood levels of FCRL5 — a protein mainly found in certain B-cells, a type of immune cell…
Mycophenolate mofetil (MMF) may be a safe and effective alternative to the standard induction therapy cyclophosphamide in certain…
Lung involvement increases the risk for both induction therapy resistance and disease relapse in ANCA-associated vasculitis (AAV) patients…
ChemoCentryx has secured a credit facility of up to $100 million from Hercules Capital to support the upcoming costs of its …
Mitochondrial DNA (mtDNA) — DNA specific to mitochondria, the cell’s powerhouses — may be used as a urinary biomarker…
Being a former or current cigarette smoker significantly increases the risk of developing ANCA-associated vasculitis (AAV), data from a…
The autoimmune condition ANCA-associated vasculitis (AAV) needs improved classification systems that can better predict disease outcomes, a Spanish study…
Antiviral therapy prevents silent reactivation of cytomegalovirus (CMV) in ANCA-associated vasculitis (AAV) patients and improves patients’ immune responses, a proof-of-concept clinical…
Excessive activation of a defense mechanism of neutrophils — key immune cells in ANCA-associated vasculitis (AAV) — is a potential biomarker…